MEDIGENE
LIVE

Serial Number

79250188

Owner

Medigene Immunotherapies GmbH

Attorney

Lisa C. Pavento

Filing Date

Jul 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MEDIGENE Trademark

Serial Number: 79250188 • Registration: 5934628

MEDIGENE is a trademark filed by Medigene Immunotherapies GmbH on July 17, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Medigene Immunotherapies GmbH (3 trademarks)

Lochhamerstrasse 11
Planegg/Martinsried , DE

Entity Type: 03

Trademark Details

Filing Date

July 17, 2018

Registration Date

December 17, 2019

Published for Opposition

October 1, 2019

Goods & Services

Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto for medical purposes

Pharmaceutical and veterinary preparations namely, cellular preparations, T-cell preparations and DC (dendritic cell) preparations for the treatment of cancer and use in immunotherapy; medical compositions for the treatment of hematological and solid tumors, tumor precursors; test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of antibodies, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of soluble T-cell receptors, test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting primarily of genetically modified cells and test kits for diagnostic preparations for medical purposes for determining the type and existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods

Services in molecular biology, namely, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits in the field of hematological and solid tumor immunology; biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific and therapeutic purposes; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 17, 2024 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 4, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 4, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 4, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 4, 2022 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 1, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 28, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2019 NONP
ASSIGNED TO LIE
Aug 29, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 22, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 22, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 22, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 22, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 14, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 14, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 5, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 1, 2019 MAFR
ASSIGNED TO EXAMINER
Jan 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 24, 2019 REPR